TECHWIRE 30
(CIX: WRAL30)  1,193.25  down arrow-0.24  (-0.02 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: Apple)  129.36  up arrow+0.27  (0.21 %)  Updated: 08:10 PM EST, Mar 03 2015
(NY: QUINTILES)  65.54    (0 %)  Updated: 06:40 PM EST, Mar 03 2015
(OP: BASF SE)  95.65  down arrow-0.06  (-0.06 %)  Updated: 05:20 PM EST, Mar 03 2015
(NQ: BioCryst)  10.06  down arrow-0.22  (-2.14 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: BioDelivery)  15.07  down arrow-0.25  (-1.63 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: CEMP)  31.96  down arrow-0.2  (-0.62 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: Cisco Systems)  29.54  down arrow-0.65  (-2.15 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: Cree)  39.49  down arrow-0.01  (-0.03 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: DARA)  0.94  down arrow-0.02  (-2.06 %)  Updated: 08:10 PM EST, Mar 03 2015
(NY: EMC CORPORATION)  28.39  down arrow-0.49  (-1.7 %)  Updated: 06:40 PM EST, Mar 03 2015
(NQ: Extreme Networks)  3.54  down arrow-0.06  (-1.67 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: FB)  79.60  down arrow-0.15  (-0.19 %)  Updated: 08:10 PM EST, Mar 03 2015
(NY: GLAXOSMITHKLINE)  47.71  down arrow-0.22  (-0.46 %)  Updated: 06:40 PM EST, Mar 03 2015
(NQ: GOOG)  573.64  up arrow+2.3  (0.4 %)  Updated: 08:10 PM EST, Mar 03 2015
(NY: IBM)  161.03  up arrow+0.55  (0.34 %)  Updated: 06:40 PM EST, Mar 03 2015
(NY: LH)  123.86  up arrow+0.5  (0.41 %)  Updated: 06:40 PM EST, Mar 03 2015
(OP: Lenovo Group)  30.80  down arrow-0.28  (-0.9 %)  Updated: 05:20 PM EST, Mar 03 2015
(NY: MRK)  58.34  down arrow-0.24  (-0.41 %)  Updated: 06:40 PM EST, Mar 03 2015
(NQ: Microsoft Corp)  43.28  down arrow-0.6  (-1.37 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: NTAP)  38.03  down arrow-0.55  (-1.43 %)  Updated: 08:10 PM EST, Mar 03 2015
(NY: NOVARTIS AG)  99.06  down arrow-1.01  (-1.01 %)  Updated: 06:40 PM EST, Mar 03 2015
(OP: Novozymes A/S)  47.60  down arrow-1.28  (-2.62 %)  Updated: 05:20 PM EST, Mar 03 2015
(NY: PFIZER)  34.56  down arrow-0.21  (-0.6 %)  Updated: 06:40 PM EST, Mar 03 2015
(NQ: Pozen)  7.25  down arrow-0.13  (-1.76 %)  Updated: 08:10 PM EST, Mar 03 2015
(NY: RED HAT)  68.50  down arrow-1.16  (-1.67 %)  Updated: 06:40 PM EST, Mar 03 2015
(NQ: BBRY)  10.97  down arrow-0.09  (-0.77 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: Salix)  156.50  down arrow-0.38  (-0.24 %)  Updated: 08:10 PM EST, Mar 03 2015
(NQ: SQI)  16.99  down arrow-0.49  (-2.8 %)  Updated: 08:10 PM EST, Mar 03 2015

Posts tagged “Novartis”

6:47 a.m. Monday

GSK, Novartis wrap up $21B asset swap, form joint venture

Drug giants GlaxoSmithKline and Novartis say they have formally closed on a deal valued at more than $21 billion to changes each company in dramatic fashion. Plus, they are moving ahead with a joint venture focusing on consumer healthcare.

A GSK-Novartis joint venture targets over-the-counter products A GSK-Novartis joint venture targets over-the-counter products

Updated February 25

Reddit, Google crack down on nude photos; GSK-Novartis deal nears close; Apple loses $539.M dispute; INC's first results; honor for Quintiles

Bulldog Bulletin In today's Bulldog wrapup of technology and life science news: Reddit and Google are cracking down on nude photos; GSK says Novartis deal nears close; Apple loses a big patent verdict; INC reports results; an honor for Quintiles.

October 27, 2014

Premium Lock #WTWTrends for Monday: Novartis, DocsInk, Durham and #IBMInsight Trending in the Triangle

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Monday, Oct. 27, 2014 as curated by @WRALTechWire.

Updated October 27, 2014

Premium Lock Novartis' Holly Springs plant sold to Australian firm in $275M deal

Drug giant Novartis is selling its $1-billion vaccine production plant in Holly Springs to Australia-based CSL as part of a deal valued at $275 million. Novartis is disposing its entire influenza-related vaccine business through this transaction that was announced Sunday night. Some 550 people work at the Holly Springs facility.

Novartis plant in Holly Springs Novartis plant in Holly Springs

September 25, 2014

Premium Lock #WTWTrends for Thursday: Red Hat's Bash Bug, Novartis, LabCorp, Sageworks spark social discussions

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Thursday as curated by @WRALTechWire.

September 25, 2014

Premium Lock Novartis ships first of new-type flu vaccine from Holly Springs plant

Pharmaceutical maker Novartis on Wednesday celebrated the U.S. Food and Drug Administration's licensing and first shipments of a new flu vaccine that the company says could drastically help with reducing a potential pandemic.

Rep. Renee Ellmers Rep. Renee Ellmers

Updated September 24, 2014

Premium Lock Novartis dedicates $1B vaccine plant with VIP flu shots as NC exec who recruited the firm will watch

It's probably a safe bet that Gov. Pat McCrory has already received his flu shot for the 2014-5 season, but he and other VIPs can line up for vaccinations today as Novartis formally dedicates production at its mammoth $1 billion plant in Holly Springs. But there's also an interesting back story to the event: The N.C. Biotechnology Center exec who helped recruit Novartis to N.C. way back in 2006.

Novartis plant in Holly Springs Novartis plant in Holly Springs

July 16, 2014

Premium Lock Yahoo earnings fall; N.C. Solar Center's new name; Novartis-Google 'Glass' contacts; Cree expands; Sling's new devices

Bulldog In today's Bulldog wrapup of technology and life science news: Yahoo takes a hit; N.C. Solar Center gets a new name; Novartis teams with Google for "Glass" contacts; Cree adds space; Sling's new devices.

June 26, 2014

Premium Lock North Carolina emerges as leader in world vaccine development

Pandemic In the third part of a series offering an overview of North Carolina's global prominence as a home for life science companies, the N.C. Biotechnology Center's Jim Shamp provides an overview of vaccine development.

June 17, 2014

Premium Lock Holly Springs' Novartis plant symbolizes healthcare revolution

The revolution has nothing to do with its proximity to the July 4 Independence Day holiday. Rather, it's in the way Flucelvax from Novartis is made at the plant. It's the first flu vaccine produced without antibiotics and preservatives, using a unique biological "soup" called cell culture.

Novartis plant in Holly Springs Novartis plant in Holly Springs

June 17, 2014

Premium Lock Novartis gets FDA nod to produce new kind of flu vaccine at Holly Springs plant

Novartis plant in Holly Springs The FDA licensed pharmaceutical firm Novartis' Holly Springs location on Monday to produce cell-culture influenza vaccines. It's the first such facility in the U.S.

April 23, 2014

Premium Lock Government contracts likely mean immunity for big Novartis vaccine plant

Plans for pharmaceutical giants Novartis, GlaxoSmithKline and Eli Lilly to swap business lines may have shaken up the stock market Tuesday, but work at a Novartis flu vaccine plant in Holly Springs hummed along, and local officials said they expect it to remain that way.

Novartis plant in Holly Springs Novartis plant in Holly Springs

Updated April 22, 2014

Premium Lock Glaxo CEO: Major deals to 'improve long-term earnings'

GSK's top executive Andrew Witty says the multiple deals announced early Tuesday with Novartis promise to deliver "broadly sustainable sourced sales growth and improve long-term earnings."

Andrew Witty     Andrew Witty

Updated April 22, 2014

Premium Lock Novartis swaps businesses with GSK, plans to sell Holly Springs plant

Novartis Two drug giants with major operations in the Triangle, Novartis and GlaxoSmithKline, are swapping businesses in two major deals. Meanwhile, Novartis plans to sell its huge Holly Springs plant in a separate deal and also strikes an agreement to sell its animal health business to Eli Lilly. No layoffs are planned, Novartis says.

Updated April 22, 2014

Premium Lock Novartis-GSK deals slide show: How they change Novartis

Drug giants Novartis and GlaxoSmithKline each offered investors online presentations that spell out graphically how the deals announced Tuesday will affect each company. Here's a look at three key slides from the Novartis presentation.

Novartis gains GSK's oncology portfolio Novartis gains GSK's oncology portfolio

Updated April 22, 2014

Premium Lock GSK-Novartis deals slide show: How they change GSK

Drug giants GlaxoSmithKline and Novartis each offered investors online presentations that spell out graphically how the deals announced Tuesday will affect each company. Here's a look at three key slides from the GSK presentation.

GSK's proposed new vaccine portfolio GSK's proposed new vaccine portfolio

January 14, 2014

Premium Lock Square worth $5B?; SAS lands big deal; PayPal's new service; Merck stock jumps; BlackBerry's new sales chief

Bulldog In our Bulldog blog's tech and life science news update: Square offers shares at $135 each; SAS signs Europe's leading drugstore chain; PayPal testing new service; Merck shares jump on drug news; BlackBerry names new sales chief and lands $250M in investment.

January 9, 2014

Premium Lock Report: Novartis looks to deal vaccine, animal health businesses to Merck

Novartis reportedly is in negotiations with fellow drug giant Merck about a $10 billion asset swap that would include the Novartis human vaccines and animal health businesses. Novartis operates a huge vaccine in Holly Springs and is building an R&D center in RTP.

Novartis plant in Holly Springs Novartis plant in Holly Springs

Updated October 22, 2013

Premium Lock SAS ranks No. 2, Quintiles No. 18 in global Great Place to Work list

Several technology and life science firms with a major presence in North Carolina crack the top 25 in the annual World's Best Multinational Workplaces ranking. NetApp, Cisco, Google, Microsoft and Novartis all make the list.

World's Best Multinational Workplaces World's Best Multinational Workplaces

October 9, 2013

Premium Lock Novartis' North Carolina vaccine team takes up arms

Employees rolled up their sleeves at the $1 billion Novartis Holly Springs vaccine manufacturing facility this week and joined the global throngs marking a revolution in the fight against flu.

Flucelvax package photo, courtesy of Novartis. Flucelvax package photo, courtesy of Novartis.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith